WARNING LETTER- Stason Pharmaceuticals, Inc.

July 8, 2020 Dear Mr. Fan: The U.S. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Stason Pharmaceuticals, Inc., FEI 1000160561, at 11 Morgan, Irvine, from October 3 to 25, 2019. This warning letter summarizes significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. See Title 21 Code of Federal …

WARNING LETTER- Stason Pharmaceuticals, Inc. Read More »